Pfizer gets early US termination for Metsera buy
By Lewis Crofts and Flavia Fortes ( October 31, 2025, 20:22 GMT | Insight) -- Pfizer has received antitrust clearance from US authorities for its $4.9 billion deal for obesity startup company Metsera. In a positive sign for Pfizer, the company’s offer is understood to have been granted early termination Friday despite the government shutdown.Pfizer has received antitrust clearance from US authorities for its $4.9 billion deal for obesity startup company Metsera. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.